ライフサイエンスコーパス: enzyme-linked immunoassay

1 and tetanus toxoid were measured by indirect enzyme-linked immunoassay.

2 transcription polymerase chain reaction, and enzyme-linked immunoassay.

3 ne attack complex C5b-9 concentrations using enzyme-linked immunoassay.

4 d by real-time polymerase chain reaction and enzyme-linked immunoassay.

5 LA2 was measured in plasma aliquots using an enzyme-linked immunoassay.

6 drolysis of cyclic (c)GMP levels with a cGMP enzyme-linked immunoassay.

7 by PDE inhibitors were quantitated by a cGMP enzyme-linked immunoassay.

8 e changes validated by mass spectrometry and enzyme-linked immunoassay.

9 protein C (pepC10) were evaluated by kinetic enzyme-linked immunoassay.

10 eceptors were performed on plasma samples by enzyme-linked immunoassay.

11 rs by end-point dilution by use of an HTLV-I enzyme-linked immunoassay.

12 or estradiol and progesterone metabolites by enzyme-linked immunoassay.

13 ntigens was determined by flow cytometry and enzyme-linked immunoassay.

14 Plasma c-erbB-2 levels were quantified by enzyme-linked immunoassay.

15 and 15 normal donors was determined using an enzyme-linked immunoassay.

16 d IL-6 concentrations were measured using an enzyme-linked immunoassay.

17 d PACAP and its receptor (PAC1) levels using enzyme-linked immunoassay.

18 matic activity in a solution compatible with enzyme-linked immunoassays.

19 often a necessary step in the development of enzyme-linked immunoassays.

20 analyzed using cell-proliferation assays and enzyme-linked immunoassays.

21 erferon (IFN-gamma), as measured by cytokine enzyme-linked immunoassays.

22 and NS4a and E2-HVR-1 peptides were used in enzyme-linked immunoassays.

23 The pool was narrowed using an enzyme-linked immunoassay: 370 clones were tested, and s

24 Western blotting and antigen capture enzyme-linked immunoassay also confirmed an increase in

25 Enzyme-linked immunoassay analysis revealed increased ba

26 A spike protein enzyme linked immunoassay and hybrid double antigen bind

27 apoB-100] were measured by chemiluminescent enzyme-linked immunoassay and commercial assays, respect

28 avidity assay by modifying the Ortho 3.0 HCV enzyme-linked immunoassay and tested 997 serum or plasma

29 The presence of OxPL was confirmed using enzyme-linked immunoassays and immunohistochemistry of c

30 Serum myeloperoxidase was measured by enzyme-linked immunoassay, and brachial artery flow-medi

31 ar MUC5AC concentration was quantified using enzyme-linked immunoassay, and conjunctival goblet cell

32 unoblots, glycosidase digestion, intact cell enzyme-linked immunoassay, and extracellular calcium-sti

33 Serum 25(OH)D was measured by using an enzyme-linked immunoassay, and serum albumin-corrected c

34 Rubella immunoglobulin G, immunoglobulin M enzyme-linked immunoassay, and viral neutralization assa

35 On the basis of enzyme-linked immunoassays as well as cross-linking expe

36 of receptor phosphorylation determined in an enzyme-linked immunoassay, as well as by Western blottin

37 4 into the culture medium was assessed using enzyme-linked immunoassay-based antibody arrays.

38 Enzyme-linked immunoassay-based protein interaction assa

39 st homologous virus-like particles (VLPs) by enzyme-linked immunoassay but did not react with denatur

40 etion was shown, with immunofluorescence and enzyme-linked immunoassay, by loss of binding of PF sera

41 at the signal-to-noise ratio of conventional enzyme-linked immunoassays could be used to monitor GLP-

42 d seven respiratory viruses through culture, enzyme-linked immunoassay (EIA) and polymerase chain rea

43 rization and use of a sensitive and specific enzyme-linked immunoassay (EIA) for BDNF protein.

44 he conventional radioimmunoassay (RIA) to an enzyme-linked immunoassay (EIA) for the measurement of H

45 e identified by serological assays including enzyme-linked immunoassay (EIA), complement fixation (CF

46 e identified by serological assays including enzyme-linked immunoassay (EIA), complement fixation, an

47 positive results in the Platelia Aspergillus enzyme-linked immunoassay (EIA), due to contamination wi

48 atitis B surface antigen (anti-HBs) by AUSAB enzyme-linked immunoassay (EIA).

49 ter using a whole-virus IgG measles-specific enzyme-linked immunoassay (EIA).

50 to HCV (anti-HCV) using a second-generation enzyme-linked immunoassay (EIA-2), followed by recombina

51 We evaluated an enzyme-linked immunoassay (EIA; BioWhittaker) and a late

52 s with chronic HCV infection were assayed in enzyme-linked immunoassays (EIAs) for antibody binding t

53 ARS-CoV-2 virus by aptamer-antibody sandwich enzyme-linked immunoassay (ELISA) and lateral flow assay

54 We first describe the validation of an enzyme-linked immunoassay (ELISA) for quantifying adipon

55 We describe the development of an enzyme-linked immunoassay (ELISA) for quantifying insuli

56 iluminescent immunoassay (CLIA), to the Zeus enzyme-linked immunoassay (ELISA) MTTT and to Zeus ELISA

57 Last, enzyme-linked immunoassay (ELISA) was used to demonstrat

58 n tears, feces and serum were measured using enzyme-linked immunoassays (ELISA) after topical and sys

59 parable to the gold-standard technique i.e., enzyme-linked immunoassays (ELISA) with a coefficient of

60 ay and Single Molecule Array (Simoa) digital enzyme-linked immunoassays (ELISAs) for ultrasensitive m

61 Enzyme-linked immunoassays (ELISAs) were performed on or

62 Using intracellular TSH staining and enzyme-linked immunoassay for detection of secreted TSH,

63 Using immunoblots and enzyme-linked immunoassay for ICE, we demonstrate that a

64 ECD was centrally measured by enzyme linked immunoassay in available samples at baseli

65 Using an enzyme-linked immunoassay, in vitro expression of E-sele

66 on of cell surface proteins, and intact cell enzyme-linked immunoassay indicated that disruption of a

67 rdiac actin were determined using a specific enzyme-linked immunoassay (n = 80).

68 Results are validated by enzyme-linked immunoassays of the sera in a certified la

69 ese devices have been used to perform simple enzyme linked immunoassays on paper.

70 ted generation of cyclic AMP, as measured by enzyme-linked immunoassay (p = .05 polynomial regression

71 uorescent microbead-based immunoassay and/or enzyme-linked immunoassay platform to characterize the a

72 evels, as determined by Western blotting and enzyme-linked immunoassays, respectively.

73 ty shift assays, Western immunoblotting, and enzyme-linked immunoassays, respectively.

74 on occurs is presently unknown, quantitative enzyme-linked immunoassay showed the presence of the equ

75 sence of antibodies to HCV was determined by enzyme-linked immunoassay, supplementary recombinant imm

76 A Toxoplasma gondii enzyme-linked immunoassay that detects strain-specific a

77 days postinjury, and serum was collected for enzyme-linked immunoassays to quantify peripheral HMGB1.

78 ha and interleukin-6 levels were analyzed by enzymes-linked immunoassay using randomly selected plasm

79 A surrogate enzyme-linked immunoassay was reviewed to select CCP sam

80 A cGMP enzyme-linked immunoassay was used to assess phototransd

81 Enzyme-linked immunoassay was used to measure cell injur

82 Using a microarray enzyme-linked immunoassay, we found that exposure to TNF

83 By use of an enzyme-linked immunoassay, we measured the in-vitro prod

84 ith reactive rapid test results were offered enzyme-linked immunoassay, Western blot, and plasma HIV-

85 Enzyme-linked immunoassay with Px44-TRAIL showed deliver